In contrast, TP53 (gene encoding p53) mutations are rare (30%).11 On the opposite, secondary GBM are primarily characterized by TP53 mutations (65%), amplification of EGFR is not so frequent (8%) as well as p16INK4a deletion (19%) and PTEN mutation (4%). Here, CDKN2A is linked to glioblastoma.